Article

NYC System Unveils P4P Plan; Doc Union Wary

Just months after the CMS launched its value-based purchasing program, the nation's largest public hospital system has announced its own pay-for-performance project, which will tie physician bonus payments to patient-satisfaction scores, readmission rates and other metrics.

Fourteen-hospital New York City Health and Hospitals Corp. said the program will award up to a total of $59 million in incentives over three years to its 3,500 affiliated physicians.

Read the full story: http://bit.ly/WHPOHb

Source: ModernHealthcare.com

Related Videos
Dr Mingyang Song
Fran Gregory, PharmD, MBA, sitting for a video interview
Casey Koch, PharmD, sitting for a video interview
Dr K. Vish Viswanath
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Dr Raymond Osarogiagbon
1 expert in this video
Dr Kimlin Tam Ashing
1 expert in this video
1 expert in this video
Related Content
RA results from immune system disfunction, which differentiates the disease from osteoporosis, which results from wear-and-tear over time | image credit: doucefleur - stock.adobe.com
April 29th 2025

Personalized, Interdisciplinary Care Elevates RA Treatment

Kyle Munz
Jon Giles, MD, speaks to the power of personalized medicine and multidisciplinary care to enhance treatment for patients with rheumatoid arthritis (RA).
managed care cast logo
April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD
On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
The thinking around which patients are eligible for liver transplants needs to evolve, the authors noted, as the criteria used to evaluate fitness for transplant were proposed nearly three decades ago. | Image credit: Peakstock - stock.adobe.com
April 29th 2025

New Developments Warrant Rethinking HCC Transplant Criteria

Jared Kaltwasser
Downstaging and bridging strategies are changing how hepatocellular carcinoma (HCC) is treated.
Managed Care Cast Thumbnail
April 15th 2025

Personalized Care Key as Tirzepatide Use Expands Rapidly

Maggie L. Shaw John W. Ostrominski, MD
Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Dupilumab. | Image Credit: Semi - stock.adobe.com
Published: April 29th 2025 | Updated: April 29th 2025

Dupilumab Treatment for Patients With CSU: Insights From Jason Hawkes, MD, MS

Maddi Hebebrand
Jason Hawkes, MD, MS, provided an in-depth look at the potential role of dupilumab (Dupixent; Sanofi and Regeneron Pharmaceuticals) in the management of chronic spontaneous urticaria (CSU), a condition with limited therapeutic options over the past decade.
The impact loneliness extends beyond one's mental health | image credit: panitan - stock.adobe.com
April 29th 2025

Loneliness Poses a Clinical Risk for Patients With Chronic Illness

Kyle Munz
A new survey highlights how the mental toll of loneliness trickles down to have very real physical consequences for patients with chronic illness.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo